Industry Primer — Healthcare
Telehealth and digital health encompasses virtual care delivery, remote patient monitoring, digital therapeutics, and online pharmacy platforms. The sector experienced explosive growth during COVID, with virtual visit volumes increasing 40-80x from pre-pandemic levels before normalizing. Current telehealth utilization represents roughly 5-7% of total outpatient visits, stabilized well above the sub-1% pre-COVID baseline. The sector spans synchronous video visits, asynchronous messaging, remote monitoring devices, and hybrid care models. Business models include direct-to-consumer (Hims, Teladoc), employer/payer contracted (Teladoc, Amwell), and technology platform licensing.
The sector is in a post-hype normalization phase. Teladoc's write-down of Livongo signaled overvaluation during the COVID bubble. However, underlying utilization trends remain positive — behavioral health telehealth in particular has sustained 30-40% of visits virtually. The key near-term catalyst is permanent telehealth reimbursement parity legislation, which remains in extension mode rather than permanent codification. Direct-to-consumer models (Hims & Hers) are showing strong growth in GLP-1 weight loss, sexual health, and dermatology. Remote patient monitoring adoption is accelerating in Medicare Advantage populations.
Over five years, telehealth will become the default entry point for non-emergency care. Hybrid models combining virtual triage with in-person follow-up will be standard. Remote patient monitoring for chronic conditions (diabetes, heart failure, COPD, hypertension) will reduce hospitalizations and total cost of care. AI-powered symptom assessment and triage will route patients efficiently. The direct-to-consumer market will expand into chronic disease management beyond the current focus on sexual health and dermatology. Expect consolidation as unprofitable pure-play telehealth companies are acquired by health systems and payers.
Long-term, the distinction between telehealth and healthcare will blur — virtual capabilities will be embedded in all care delivery. Continuous remote monitoring through wearables and home diagnostics will enable proactive intervention. AI clinical assistants will handle routine consultations with physician oversight. Global telehealth — U.S. providers serving international patients — will emerge as a growth channel. The key risk is that telehealth becomes commoditized, with value accruing to the underlying AI and data platforms rather than the virtual visit itself.
Reimbursement parity between virtual and in-person visits determines provider adoption. State licensure requirements and interstate compact participation affect geographic scalability. Patient adoption and digital literacy, particularly among elderly populations, influence utilization. Technology infrastructure (broadband access, device availability) creates access disparities. Clinical evidence demonstrating outcome equivalence is necessary for specialty expansion. Regulatory framework for AI-assisted diagnosis in telehealth settings remains evolving.
AI is central to telehealth's evolution. AI triage bots provide initial symptom assessment and care routing, handling 30-40% of inquiries without clinician involvement. Computer vision enables dermatological diagnosis through smartphone photos. NLP powers asynchronous care models where AI drafts clinical responses for physician review. Remote monitoring AI detects concerning trends in vital signs before they become emergencies. AI-driven personalization tailors treatment protocols based on individual patient data, genetics, and behavioral patterns.
Telehealth and digital health companies can leverage AI-powered triage and symptom assessment tools that route patients to the appropriate level of care, improving clinician efficiency. Automated scheduling and queue management optimize provider utilization. NLP-driven clinical documentation reduces post-visit charting burden. Remote patient monitoring platforms with AI-driven alerting extend the care model beyond episodic visits. Patient engagement analytics improve retention and outcomes — key metrics for enterprise health system contracts.
Teladoc Health (TDOC) is the largest pure-play telehealth company with integrated virtual care and chronic condition management. Hims & Hers Health (HIMS) operates a direct-to-consumer telehealth platform across multiple health categories. Amwell (AMWL) provides a telehealth technology platform for health systems and payers. Talkspace (TALK) offers virtual behavioral health services. Accolade (ACCD) provides personalized health navigation and virtual care. LifeStance Health (LFST) operates outpatient mental health practices with significant virtual delivery.